JP5075969B2 - マイコバクテリウム・ツベルクローシスｅｓａｔ−６遺伝子ファミリーベースの結核ワクチン及び診断法 - Google Patents

マイコバクテリウム・ツベルクローシスｅｓａｔ−６遺伝子ファミリーベースの結核ワクチン及び診断法 Download PDF

Info

Publication number
JP5075969B2
JP5075969B2 JP2010262852A JP2010262852A JP5075969B2 JP 5075969 B2 JP5075969 B2 JP 5075969B2 JP 2010262852 A JP2010262852 A JP 2010262852A JP 2010262852 A JP2010262852 A JP 2010262852A JP 5075969 B2 JP5075969 B2 JP 5075969B2
Authority
JP
Japan
Prior art keywords
oligopeptide
polypeptide
ifn
composition according
positive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010262852A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011102299A5 (fr
JP2011102299A (ja
Inventor
アンデルセン，ペーター
スクジョ，リッケ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Statens Serum Institut SSI
Original Assignee
Statens Serum Institut SSI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Serum Institut SSI filed Critical Statens Serum Institut SSI
Publication of JP2011102299A publication Critical patent/JP2011102299A/ja
Publication of JP2011102299A5 publication Critical patent/JP2011102299A5/ja
Application granted granted Critical
Publication of JP5075969B2 publication Critical patent/JP5075969B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP2010262852A 1999-07-13 2010-11-25 マイコバクテリウム・ツベルクローシスｅｓａｔ−６遺伝子ファミリーベースの結核ワクチン及び診断法 Expired - Fee Related JP5075969B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA199901020 1999-07-13
DKPA199901020 1999-07-13
US14401199P 1999-07-15 1999-07-15
US60/144,011 1999-07-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001509760A Division JP5010079B2 (ja) 1999-07-13 2000-07-13 マイコバクテリウム・ツベルクローシスｅｓａｔ−６遺伝子ファミリーベースの結核ワクチン及び診断法

Publications (3)

Publication Number Publication Date
JP2011102299A JP2011102299A (ja) 2011-05-26
JP2011102299A5 JP2011102299A5 (fr) 2012-06-07
JP5075969B2 true JP5075969B2 (ja) 2012-11-21

Family

ID=44192802

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010262852A Expired - Fee Related JP5075969B2 (ja) 1999-07-13 2010-11-25 マイコバクテリウム・ツベルクローシスｅｓａｔ−６遺伝子ファミリーベースの結核ワクチン及び診断法

Country Status (1)

Country Link
JP (1) JP5075969B2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3084442T (lt) * 2013-12-16 2021-07-12 Statens Serum Institut Diagnostiniai reagentai, skirti pagerintai in vivo arba in vito ląstelių medijuojamai imunologinei tuberkuliozės diagnozei

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555653B2 (en) * 1997-05-20 2003-04-29 Corixa Corporation Compounds for diagnosis of tuberculosis and methods for their use

Also Published As

Publication number Publication date
JP2011102299A (ja) 2011-05-26

Similar Documents

Publication Publication Date Title
AU2008224343B2 (en) Tuberculosis vaccine and diagnostics based on the Mycobacterium tuberculosis esat-6 gene family
US8142797B2 (en) Therapeutic TB vaccine
JP4544434B2 (ja) 結核菌由来の核酸フラグメント及びポリペプチドフラグメント
US8076469B2 (en) TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) Hybrids of M. tuberculosis antigens
AU9433898A (en) Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
AU2001250294A1 (en) Tuberculosis antigens and methods of use thereof
JP2003510018A5 (fr)
WO2005061534A2 (fr) Vaccins antituberculeux ameliores
AU766093B2 (en) Tuberculosis vaccine and diagnostic reagents based on antigens from the mycobacterium tuberculosis cell
US20040013685A1 (en) Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
AU2012202486B2 (en) Tuberculosis vaccine and diagnostics based on the Mycobacterium tuberculosis esat-6 gene family
JP5075969B2 (ja) マイコバクテリウム・ツベルクローシスｅｓａｔ−６遺伝子ファミリーベースの結核ワクチン及び診断法
US7041295B2 (en) Compounds for treatment of infectious and immune system disorders and methods for their use
US6358734B1 (en) Compounds for treatment of infectious and immune system disorders and methods for their use
ANDERSEN et al. Patent 2378763 Summary
EP1484405A1 (fr) Fragments d'acide nucléique et fragments polypeptidiques derivés de M. tuberculosis
AU2013206297A1 (en) Tuberculosis vaccines comprising antigens expressed during the latent infection phase
EP1787994A1 (fr) Vaccin et diagnostic TB selon les antigènes de la cellule du bacille de koch

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120412

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120731

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120827

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150831

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees